Skip to site content

2021 Catalog: All Courses

To view other courses in this category, use the “Previous” and “Next” buttons. To select this course and request approval, please login. Need more help reading this page?



DE0428: Diabetes Online CDE: Cancer and Cancer Screening in AI/AN People with Diabetes

 
Date: 4/27/2021 - 4/27/2021
Course Status: Available
Facility: Online
Location: Online
Instructor: Lani Desaulniers
Director: Jan Frederick
Level: Basic
Audience: Dentists, Hygienists, Assistants
Quota: 1 - 1000 students
Tuition: $0.00
Hours: 1.00 (Total CDE); 1.00 (DANB Non-Clinical); 1.00 (AGD - 149)
Lecture icon Question and Answer icon
The IHS Division of Oral Health is an ADA CERP Recognized Provider
The IHS Division of Oral Health is an ADA CERP Recognized Provider
Summary:

People with diabetes are at increased risk for several types of cancer [liver, endometrium, breast, colorectal and bladder] and they can experience worse outcomes than the general population. Similar disparities in risk and outcomes have been described in the AI/AN population.

This session will provide an overview of the epidemiology of cancer in people with diabetes and in the AI/AN population, and strategies for cancer risk reduction. An overview of current cancer screening recommendations will be presented. The role of the diabetes care team in promoting cancer screening as part of routine diabetes care will be addressed, particularly in the post-COVID era when people may have deferred routine care and testing.

Learning Objectives:

Upon completion of this course, participants will be able to:
1. Identify the most common diagnosed cancers among diabetics and AI/AN populations.
2. Implement strategies for cancer risk reduction.
3. Examine current guidelines for cancer screening.






Disclosure Policy:

It is the policy of the Indian Health Service, Division of Oral Health, that faculty/planners disclose any financial or other relationships with commercial companies whose products may be discussed in the educational activity. The Indian Health Service, Division of Oral Health, also requires that faculty disclose any unlabeled or investigative use of pharmaceutical products and medical devices. Images that have been falsified or manipulated to misrepresent treatment outcomes are prohibited.

None of the faculty/planners for this activity has a conflict of interest, and there is no use of unlabeled or investigative pharmaceutical products or medical devices. No images have been falsified or manipulated to misrepresent treatment outcomes.The educational objectives, content, and selection of educational methods and instructors are conducted independent of any commercial entity.

Concerns or complaints about this course may be directed to IHS CDE Coordinator or to ADA CERP (http://www.ada.org/goto/cerp).

Prerequisites:

None

Tuition Payment Information:

NA

Tuition Policy:

Tuition must be paid in full 8 weeks prior to the start date of any course. Request for refunds must be received in writing at least two weeks before the course begins. For each refund request, there will be an administrative charge of $100. No refunds will be made to registrants who fail to attend a course. If IHS CDE program cancels a course, then 100% of the tuition will be refunded.